What one share of Corbus Pharmaceuticals Holdings holds
Corbus Pharmaceuticals Holdings, Inc. (the “Company” or “Corbus”) is a clinical stage company focused on promising new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways.
Corbus Pharmaceuticals Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$6.10 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$5.19 |
| Cash and investments | $1.25 |
| Book value | $5.48 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | −$2.70 | — | — | — | −$7.68 |
| 2014 | — | −$3.90 | $0.10 | −$3.61 | — | $6.78 |
| 2015 | $0.62 | −$8.47 | $0.11 | −$4.53 | — | $7.17 |
| 2016 | $1.39 | −$14.58 | $0.26 | −$10.15 | — | $5.99 |
| 2017 | $1.46 | −$19.38 | $0.42 | −$17.04 | — | $31.18 |
| 2018 | $2.54 | −$29.30 | $1.21 | −$17.04 | — | $14.42 |
| 2019 | $16.97 | −$33.55 | $1.29 | −$22.75 | — | $2.86 |
| 2020 | $1.51 | −$42.72 | $0.19 | −$38.46 | — | $13.74 |
| 2021 | $0.22 | −$11.15 | $0.01 | −$11.78 | — | $16.57 |
| 2022 | $0.00 | −$10.15 | $0.00 | −$9.01 | — | $7.91 |
| 2023 | — | −$10.31 | $0.00 | −$8.34 | — | −$1.56 |
| 2024 | — | −$3.68 | $0.00 | −$3.83 | — | $11.69 |
| 2025 | — | −$5.90 | $0.00 | −$4.84 | — | $8.38 |
Common questions about Corbus Pharmaceuticals Holdings
How much does one share of Corbus Pharmaceuticals Holdings earn?
Over the last 12 months, Corbus Pharmaceuticals Holdings lost $6.10 for each share.
Does Corbus Pharmaceuticals Holdings pay a dividend?
Corbus Pharmaceuticals Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Corbus Pharmaceuticals Holdings’s book value per share?
Corbus Pharmaceuticals Holdings’s book value is $5.48 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Corbus Pharmaceuticals Holdings have?
Each share of Corbus Pharmaceuticals Holdings has $1.25 of cash and investments, as of June 30, 2026.
What is Corbus Pharmaceuticals Holdings’s free cash flow per share?
−$5.19 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Corbus Pharmaceuticals Holdings bought back shares?
Corbus Pharmaceuticals Holdings’s share count rose about 5636% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.